Literature DB >> 7681966

Electrophysiological behavior of atrioventricular node after selective fast or slow pathway ablation in patients with atrioventricular nodal reentrant tachycardia.

M R Jazayeri1, M Akhtar.   

Abstract

One hundred twenty consecutive patients with symptomatic atrioventricular nodal reentrant tachycardia (AVNRT) underwent catheter ablation using radiofrequency energy. Fast pathway ablation was attempted in the first 16 consecutive patients by application of radiofrequency current in the anterior and superior aspect of the tricuspid annulus. Successful results were accomplished in 13 patients, complete atrioventricular (AV) block occurred in three. One hundred four patients underwent ablation of the slow pathway in the posterior and inferior aspect of the tricuspid annulus, which was successful in 98 patients. The remaining six patients subsequently underwent a fast pathway ablation with successful results in four and AV block in two. Therefore, 102 (98%) of the last 104 patients became free of AVNRT while maintaining intact AV conduction. This study characterizes the electrophysiological properties of the residual AV node following a selective fast or slow pathway ablation.

Entities:  

Mesh:

Year:  1993        PMID: 7681966     DOI: 10.1111/j.1540-8159.1993.tb01634.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  2 in total

1.  Slow pathway modification for atrioventricular node re-entrant tachycardia: fast junctional tachycardia predicts adverse prognosis.

Authors:  K J Lipscomb; A M Zaidi; A P Fitzpatrick; D Lefroy
Journal:  Heart       Date:  2001-01       Impact factor: 5.994

2.  Selective atrionodal input ablation for induction of proximal complete heart block with stable junctional escape rhythm in patients with uncontrolled atrial fibrillation.

Authors:  Bernhard Strohmer; Chun Hwang; C Thomas Peter; Peng-Sheng Chen
Journal:  J Interv Card Electrophysiol       Date:  2003-02       Impact factor: 1.900

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.